Pediatric Surgery—Current Hurdles and Future Perspectives

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Clinical Pediatrics".

Deadline for manuscript submissions: 27 June 2025 | Viewed by 4500

Special Issue Editor


E-Mail Website
Guest Editor
Department of Pediatric Surgery, Shamir Medical Center, Zerifin 70300, Israel
Interests: pediatric surgery; congenital anomalies; pediatric surgical oncology; trauma

Special Issue Information

Dear Colleagues,

The Journal of Clinical Medicine (JCM) is now introducing a special review series that will update our clinical and scientific community regarding the recent advances in pediatric surgery. We invite state-of-the-art reviews on current topical issues in pediatric surgery, including both clinical science and basic science. Pediatric surgery is a relatively new area of clinical medicine and surgery, with many unanswered questions regarding the natural history of disease, pathogenesis, and evidence-based therapies. Many of us worldwide are dedicating significant efforts to studying the large variety of medical conditions which pose challenges to the pediatric surgeon, and data have been gathered, with subsequent changes to traditional treatment options. Our understanding of the natural history of diseases that the pediatric patients and the pediatric surgeons are coping with is limited by the small numbers of patients with certain conditions and by the need for a very long follow-up. The long-term sequala of esophageal atresia, for example, and the need for follow-ups into adulthood have recently been recognized. Another example includes innovative surgical techniques to treat relatively common anorectal malformations, which challenge traditional techniques with fewer complications and excellent outcomes. Trauma paradigms have also been challenged, and using whole blood, as one example, is providing better survival outcomes for severely injured children. To address the important questions dealt within our daily clinical practices and to promote future research and improvements, we sincerely welcome your submissions to this Special Issue in the JCM. I hope that by reading this Special Issue, the readership of JCM will be able to advance the treatment of their patients and to further contribute to research.

Dr. Osnat Zmora
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • congenital anomalies
  • esophageal atresia
  • anorectoal malformations
  • pediatric trauma
  • necrotizing enterocoloitis
  • pediatric oncology
  • Biliary atresia

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (5 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

10 pages, 1146 KiB  
Article
Outcomes of Tympanoplasty with an Autologous Two-Piece Perichondrium-Cartilage Graft in a Tertiary Care Setting
by Marie Reynders, Dylen Philips, Kelsey Van Den Houte, Lynn Van Der Sypt, Camille Levie and Ina Foulon
J. Clin. Med. 2025, 14(8), 2600; https://doi.org/10.3390/jcm14082600 - 10 Apr 2025
Viewed by 284
Abstract
Background/Objectives: This study evaluates the anatomical and functional outcomes of type 1 tympanoplasty using an autologous two-piece perichondrium-cartilage (CP) graft in pediatric and adult patients with tympanic membrane (TM) perforations. Methods: A retrospective review of 74 patients (59 children, 15 adults) [...] Read more.
Background/Objectives: This study evaluates the anatomical and functional outcomes of type 1 tympanoplasty using an autologous two-piece perichondrium-cartilage (CP) graft in pediatric and adult patients with tympanic membrane (TM) perforations. Methods: A retrospective review of 74 patients (59 children, 15 adults) undergoing type 1 tympanoplasty with CP by a single surgeon (IF) was conducted. Preoperative and postoperative audiological outcomes, perforation size, prognostic factors, and complications were analyzed. Success was defined as an intact TM and an air–bone gap (ABG) < 20 dBHL at 12 months postoperatively. Results: TM closure was achieved in 93.2% of patients, with 93.1% attaining an ABG < 20 dBHL. The combined success rate was 86.3%, with no significant differences between children and adults. Larger perforations (>50%) had significantly lower closure rates (55.6% vs. >97%, p < 0.002). Children who underwent prior adenoidectomy had significantly higher success rates (p = 0.04). Conclusions: Tympanoplasty with a CP graft provides high success rates in both children and adults. The procedure can be performed from age five, considering patient cooperation. In children, simultaneous adenoidectomy is recommended if significant adenoid hypertrophy is present to optimize outcomes. Larger perforations were associated with reduced success, while age had no significant impact. Full article
(This article belongs to the Special Issue Pediatric Surgery—Current Hurdles and Future Perspectives)
Show Figures

Figure 1

18 pages, 16760 KiB  
Article
Primary Lung Tumors in Children: Insights from a Single-Center Case Series
by Paola Borgia, Barbara Cafferata, Claudio Paratore, Lorenzo Anfigeno, Alessio Conte, Angelo Florio, Annalisa Gallizia, Marco Del Monte, Francesca Buffelli, Francesca Rizzo, Maria Beatrice Damasio, Pietro Salvati, Katia Perri, Alberto Garaventa, Teresa Battaglia, Virginia Livellara, Massimo Conte, Giovanni Arturo Rossi, Valerio Gaetano Vellone, Michele Torre, Carlo Castellani and Oliviero Saccoadd Show full author list remove Hide full author list
J. Clin. Med. 2025, 14(7), 2173; https://doi.org/10.3390/jcm14072173 - 22 Mar 2025
Viewed by 501
Abstract
Background: Primary lung tumors in pediatric patients are rare, predominantly malignant, and present diagnostic challenges due to symptom overlap with more common conditions such as inflammatory processes or asthma. Evidence-based approaches for managing these rare neoplasms in childhood are scarce. This retrospective [...] Read more.
Background: Primary lung tumors in pediatric patients are rare, predominantly malignant, and present diagnostic challenges due to symptom overlap with more common conditions such as inflammatory processes or asthma. Evidence-based approaches for managing these rare neoplasms in childhood are scarce. This retrospective study reports the experience of a pediatric referral center in diagnosing and treating these tumors. Methods: Pediatric primary lung tumors treated at Giannina Gaslini Children’s Hospital between January 2016 and January 2024 were included. Data on clinical presentation, histopathology, imaging, treatment approaches, and outcomes were systematically collected and analyzed. Results: Nine patients (six males and three females) were identified, with a mean age (±SD) at diagnosis of 8.81 ± 5 years. The most common clinical manifestation was recurrent pneumonia (four patients), followed by persistent cough and wheezing (three patients). The average duration of symptoms before diagnosis was 12.8 months ± 12.2 months. Histopathological diagnoses were typical carcinoid tumors (n = 2), atypical carcinoid tumors (n = 2), inflammatory myofibroblastic tumors (n = 2), congenital peribronchial myofibroblastic tumor (n = 1), myoepithelial carcinoma (n = 1), and pleuropulmonary blastoma (n = 1). Radical surgery resulted in complete response for seven patients, with a median follow-up of 52 months (IQR 39 months). The myoepithelial carcinoma was treated with multimodal therapy, relapsed after 17 months, and adjuvant chemotherapy is currently ongoing. Neoadjuvant chemotherapy for the pleuropulmonary blastoma is currently ongoing. Conclusions: Primary lung tumors in children, though rare, may have favorable outcomes when appropriately managed. Nonspecific clinical presentations often contribute to diagnostic delays. This study highlights the critical need of thorough evaluation in cases of persistent, therapy-resistant aspecific respiratory symptoms. Early diagnosis, coupled with complete surgical resection, significantly improves prognosis. Full article
(This article belongs to the Special Issue Pediatric Surgery—Current Hurdles and Future Perspectives)
Show Figures

Figure 1

9 pages, 216 KiB  
Article
Is There a Pediatric Role for the General Thoracic Surgeon in a General Hospital? A 22-Year Single-Center Experience
by Francesco Petrella, Sara Degiovanni, Federico Raveglia, Andrea Cara, Enrico Mario Cassina, Francesca Graziano, Lidia Libretti, Emanuele Pirondini, Sara Vaquer, Antonio Tuoro, Giuseppe Foti, Alessandra Moretto, Alessandro Cattoni, Andrea Biondi and Adriana Balduzzi
J. Clin. Med. 2024, 13(23), 7231; https://doi.org/10.3390/jcm13237231 - 28 Nov 2024
Viewed by 607
Abstract
Background: Although general thoracic surgery is usually focused on adult patients, there are some settings of pediatric diseases which can benefit from thoracic surgical procedures. In this study, we retrospectively reviewed the contribution of general thoracic surgeons to pediatric patients in a [...] Read more.
Background: Although general thoracic surgery is usually focused on adult patients, there are some settings of pediatric diseases which can benefit from thoracic surgical procedures. In this study, we retrospectively reviewed the contribution of general thoracic surgeons to pediatric patients in a high-volume hospital. Methods: From September 2002 to August 2024, 8897 consecutive patients were operated on; among them, 202 patients (2.2%) were younger than 18. Age, sex, operatory setting, side, indications, procedures, procedure duration, and perioperative mortality were collected for each patient. Results: Among the 202 patients younger than 18, 27 (13.3%) were 0–6 yo; 13 (6.4%) were 6–12 yo; 162 (80.1%) were 12–18 yo. In the first group, metapneumonic pleural effusion was the most frequent indication (44.4%) and chest drain the most frequent procedure (51.8%). No perioperative mortality was reported. In the second group, metapneumonic pleural effusion was the most frequent indication (30.7%) and chest drain the most frequent procedure (46.1%). No perioperative mortality was reported. In the third group, pneumothorax was the most frequent indication (41.3%) and bullectomy the most frequent procedure; (41.3%); one intraoperative death (0.4%) was reported in a case of major trauma. Conclusions: A general thoracic surgeon can effectively contribute to the surgical care of pediatric patients; in younger patients (<12 yo) urgent procedures related to infections are the most commonly performed; on the other hand, in patients aged between 12 and 18, elective procedures are more commonly performed, these being sympathectomy for hyperhidrosis and bullectomy for pneumothorax the most frequent. Full article
(This article belongs to the Special Issue Pediatric Surgery—Current Hurdles and Future Perspectives)
17 pages, 2400 KiB  
Article
Maximizing Survival in Pediatric Congenital Cardiac Surgery Using Machine Learning, Explainability, and Simulation Techniques
by David Mauricio, Jorge Cárdenas-Grandez, Giuliana Vanessa Uribe Godoy, Mirko Jerber Rodríguez Mallma, Nelson Maculan and Pedro Mascaro
J. Clin. Med. 2024, 13(22), 6872; https://doi.org/10.3390/jcm13226872 - 15 Nov 2024
Viewed by 1125
Abstract
Background: Pediatric and congenital heart surgery (PCHS) is highly risky. Complications associated with this surgical procedure are mainly caused by the severity of the disease or the unnecessary, late, or premature execution of the procedure, which can be fatal. In this context, prognostic [...] Read more.
Background: Pediatric and congenital heart surgery (PCHS) is highly risky. Complications associated with this surgical procedure are mainly caused by the severity of the disease or the unnecessary, late, or premature execution of the procedure, which can be fatal. In this context, prognostic models are crucial to reduce the uncertainty of the decision to perform surgery; however, these models alone are insufficient to maximize the probability of success or to reverse a future scenario of patient death. Method: A new approach is proposed to reverse the prognosis of death in PCHS through the use of (1) machine learning (ML) models to predict the outcome of surgery; (2) an explainability technique (ET) to determine the impact of main risk factors; and (3) a simulation method to design health scenarios that potentially reverse a negative prognosis. Results: Accuracy levels of 96% in the prediction of mortality and survival were achieved using a dataset of 565 patients undergoing PCHS and assessing 10 risk factors. Three case studies confirmed that the ET known as LIME provides explanations that are consistent with the observed results, and the simulation of one real case managed to reverse the initial prognosis of death to one of survival. Conclusions: An innovative method that integrates ML models, ETs, and Simulation has been developed to reverse the prognosis of death in patients undergoing PCHS. The experimental results validate the relevance of this approach in medical decision-making, demonstrating its ability to reverse negative prognoses and provide a solid basis for more informed and personalized medical decisions. Full article
(This article belongs to the Special Issue Pediatric Surgery—Current Hurdles and Future Perspectives)
Show Figures

Graphical abstract

10 pages, 1962 KiB  
Article
Infectious Diseases-Approved Virtual Reality Goggles for Common Procedures in Pediatric Surgical Patients
by Yarden Gilboa Pras, Atara Indursky, Shai Gilboa Pras, Ortal Schaffer, Eleonora Niazov and Osnat Zmora
J. Clin. Med. 2024, 13(18), 5572; https://doi.org/10.3390/jcm13185572 - 20 Sep 2024
Viewed by 1173
Abstract
Background/Objective: Virtual reality (VR) technology has been reported as effective in mitigating fear, anxiety, and pain in children undergoing various medical procedures. Our aim was to test the effectiveness of non-sponge-coated mobile phone-operated VR goggles approved by infectious diseases (ID) control in [...] Read more.
Background/Objective: Virtual reality (VR) technology has been reported as effective in mitigating fear, anxiety, and pain in children undergoing various medical procedures. Our aim was to test the effectiveness of non-sponge-coated mobile phone-operated VR goggles approved by infectious diseases (ID) control in pediatric surgical patients. Methods: A prospective randomized trial in which pre-procedural and post-procedural heart rate, fear, and anxiety, and post-procedural pain were measured in pediatric surgical patients assigned to receive standard care versus standard care and VR goggles. The patients underwent line insertions, peripheral venipunctures for blood draws, drain removals, and wound care. Results: The control group and the intention-to-treat group were each randomly assigned twenty-four patients. Since eight patients who received VR goggles removed them prior to completion of the procedure, the study group included sixteen patients. In the study group, heart rate, fear, and anxiety scores were significantly lower after the procedure as compared to prior to the procedure. In the control group, these parameters were similar before and after the procedure. Post-procedural decrease in fear and anxiety was significant when comparing VR to control. However, despite better post-procedural physiological and emotional scores in the VR group as compared to control, the differences were not statistically significant. Pre-procedural anxiety was significantly higher in the study group. Conclusions: ID-approved VR goggles can reduce fear and anxiety associated with procedures commonly performed in pedicatric surgical patients. However, since increased baseline anxiety might be associated with VR, a higher benefit might be achieved if goggles were worn only by children who express a clear desire to use them. Full article
(This article belongs to the Special Issue Pediatric Surgery—Current Hurdles and Future Perspectives)
Show Figures

Figure 1

Back to TopTop